ivabradine

Design and rationale of RECOVER-AUTONOMIC: A randomized platform trial evaluating interventions for Long COVID postural orthostatic tachycardia syndrome Abstract Background: Post‑acute sequelae of SARS‑CoV‑2 infection (Long COVID) affect a substantial proportion of individuals, and among the...

Ivabradine as a treatment for postural orthostatic tachycardia syndrome: A systematic review Abstract Ivabradine is one of several off-label treatments for patients with postural orthostatic tachycardia syndrome (POTS). We conducted a systematic review of the literature to identify studies...

Heart Rate Lowering with Ivabradine and Burden of Symptoms in Patients with Postural Orthostatic Tachycardia Syndrome Marchetta, Michele; Lopez, Rocio I.; Hogwood, Austin C.; Thomas, Georgia; Abbate, Gerardina; Markley, Roshanak; Canada, Justin M.; Abbate, Antonio [Line breaks added] Abstract...

Ivabradine effects on COVID-19-associated postural orthostatic tachycardia syndrome: a single center prospective study Background: A wide range of cardiac arrhythmias were reported in the setting of active infection or as a complication of COVID-19. The main pathophysiology can be attributed...

Comparative Cohort Study of Post-Acute Covid-19 Infection with a Nested, Randomized Controlled Trial of Ivabradine for Those With Postural Orthostatic Tachycardia Syndrome (The COVIVA Study) David Saunders; Thomas B Arnold; Jason M Lavendar; Daoqin Bi; Karl Alcover; Lydia D Hellwig; Sahar T...

Paywalled at https://link.springer.com/article/10.1007%2Fs40256-017-0252-1